Gain Therapeutics updates shareholders on the advancement of GT-02287 for Parkinson's disease, highlighting key clinical trial milestones and funding support. Gain Therapeutics, Inc. has announced ...
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Gain Therapeutics ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results